The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hin, S.
Right arrow Articles by Walden, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hin, S.
Right arrow Articles by Walden, P.
The Journal of Immunology, 1999, 163: 2363-2367.
Copyright © 1999 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: N-Hydroxy Peptides: A New Class of TCR Antagonists1

Sascha Hin*, Claus Zabel*, Alberto Bianco2,{dagger}, Günther Jung{dagger} and Peter Walden3,*

* Department of Dermatology, Medical Faculty Charité, Humboldt University, Berlin, Germany; and {dagger} Institute for Organic Chemistry, University of Tübingen, Tübingen, Germany

TCR antagonists are altered T cell epitopes that specifically inactivate T cells. Commonly, they are derived from agonists by amino acid side chain replacement at positions accessible to the TCR. In this paper we report for the first time that a main chain N-hydroxylation, which is not exposed at the surface of the MHC peptide complex, renders an agonist into an antagonist. These mimotopes are a new, yet undescribed class of TCR antagonists. The antagonists are about 100 times more potent than an unrelated peptide that competes for binding to the MHC molecule. The novel main chain modification enhances biostability and maintains side chain constitution and thus opens new prospects for the use of TCR antagonists in the treatment of pathological immune reactions.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Garcia-Peydro, A. Paradela, J. P. Albar, and J. A. L. d. Castro
Antagonism of Direct Alloreactivity of an HLA-B27-Specific CTL Clone by Altered Peptide Ligands of Its Natural Epitope
J. Immunol., November 15, 2000; 165(10): 5680 - 5685.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Hin, A. Bianco, C. Zabel, G. Jung, and P. Walden
Mimetics of a T Cell Epitope Based on Poly-N-acylated Amine Backbone Structures Induce T Cells in Vitro and in Vivo
J. Biol. Chem., December 21, 2001; 276(52): 48790 - 48796.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.